Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.5.2 was added, and the previous revision v3.5.0 was removed from the page history.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check39 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing Revision: v3.4.2 as part of a site update. This change does not affect study data or content on the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting; the update adds Study Status and Contacts/Locations sections on 2026-02-27.SummaryDifference0.3%

- Check68 days agoChange DetectedA new Revision: v3.4.2 was added to the History, while the funding-status notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedA site-wide notice about government funding status was added and the revision updated to v3.4.1 on 2026-02-02, while the prior v3.4.0 revision was deleted on 2026-01-05.SummaryDifference0.6%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.